PMID: 15222872Jun 30, 2004Paper

Intravenous PGE-1 in peripheral vascular obstructive disease: use over a 6-month period

Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria
J Llorente GutiérrezE Jiménez Caballero

Abstract

The main goal of this study is to assess PGE-1 use by measuring and stratifying its effectiveness according to patient condition, using clinical parameters. Standard therapy consists of intravenous infusion for 21 days. A revision of 30 medical records was carried out on 28 men and 2 women with a mean age of 69.71 -- SD 14.84 -- years who had been treated with PGE1. Twenty-six patients had a diagnosis of chronic arterial ischemia (6 Grade I-II, 20 Grade III-IV), and 4 of diabetic gangrene. The following clinical parameters were measured both before and after therapy -- pain, distal perfusion, and necrotic lesions according to TASC (Transatlantic Inter-Society Consensus). Before treatment onset, 30 patients had pain and decreased distal perfusion, and 20 patients had necrotic lesions. Six patients discontinued therapy because of lesion worsening. After 21 days of treatment 18 patients continued to have pain and decreased distal perfusion, and 16 still had necrotic lesions. Stratifying results by diagnosis, those 6 patients diagnosed with grade I-II chronic arterial ischemia experienced improvement in the three clinical parameters being considered -- absence of pain and improved distal perfusion and necrotic lesions. PGE1 is a be...Continue Reading

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.